Article · 4 May 2026
ArticlePublished 17 May 2024
An Observational Study of Clinical Efficacy of Travoprost and Timolol Eye Drops for Senile Glaucoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To explore the clinical effect of travoprost and timolol eye drops for senile glaucoma. This study selected 88 individuals having senile glaucoma admitted to the Affiliated Hospital of Weifang Medical University hospital for treatment between January 2020 and January 2022. Depending on treatment regimens, they were assigned to an observation group who were given travoprost (n=47) and control group who were given timolol eye drops (n=41). The therapeutic effects, visual field defects, 24 h peak intraocular pressure, binocular optic disc parameters, adverse effects and quality of life of the two groups were analyzed. Patients in the observation group showed notably better treatment outcomes when compared with the control patients. Obvious post-treatment improvements of visual field defects, 24 h peak intraocular pressure, binocular optic disc parameters and quality of life were observed in both groups, especially in the observation group; no significant inter-group difference was determined in adverse effects. Travoprost is superior to timolol eye drops to treat primary glaucoma in older adults, which can effectively ameliorate intraocular pressure and visual field defects, with less adverse effects and high safety. Its clinical application can be beneficial and is therefore recommended to be further popularized clinically.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shanshan Fan”
- BylineArticles whose byline prints “Huijing Bao”
- BylineArticles whose byline prints “P. Qi”
- BylineArticles whose byline prints “Tong Ge”